Mixed Hyperlipemia
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage (NCT04849000) | Jiangsu HengRui Medicine Co., Ltd. | 2021-04-23 |
| MK0859 Dose-Ranging Study (0859-003) (NCT00325455) | Merck Sharp & Dohme LLC | 2006-06-01 |
Track Mixed Hyperlipemia automatically
Every clearance here is in the API, with alerts when new ones post.